Screening a protein kinase inhibitor library against Plasmodium falciparum
Abstract Background Protein kinases have been shown to be key drug targets, especially in the area of oncology. It is of interest to explore the possibilities of protein kinases as a potential target class in Plasmodium spp., the causative agents of malaria. However, protein kinase biology in malari...
Main Authors: | Irene Hallyburton, Raffaella Grimaldi, Andrew Woodland, Beatriz Baragaña, Torsten Luksch, Daniel Spinks, Daniel James, Didier Leroy, David Waterson, Alan H. Fairlamb, Paul G. Wyatt, Ian H. Gilbert, Julie A. Frearson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Malaria Journal |
Online Access: | http://link.springer.com/article/10.1186/s12936-017-2085-4 |
Similar Items
-
Identification of Inhibitors of the Leishmania cdc2-Related Protein Kinase CRK3
by: Cleghorn, L, et al.
Published: (2011) -
Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesis.
by: Baragaña, B, et al.
Published: (2016) -
Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia.
by: Kristina Kesely, et al.
Published: (2020-01-01) -
Erythrocyte sphingosine kinase regulates intraerythrocytic development of Plasmodium falciparum
by: Raj Kumar Sah, et al.
Published: (2021-01-01) -
Anti-malarial drugs: how effective are they against <it>Plasmodium falciparum </it>gametocytes?
by: Peatey Christopher L, et al.
Published: (2012-02-01)